Search

for
Search:

Research

5 / 1000+ results

research The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease

January 2013 in “Yearbook of Urology”

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

research Aesthetics in psychosomatic dermatology II. skin changes experienced as cutaneous disease

1 citations , October 1984 in “Clinics in dermatology”

People distressed by minor skin changes should consult dermatologists with cosmetic expertise, and a public Cosmetic Dermatology Service with mental health support is recommended.

research Shock: A possible presenting manifestation of autoimmune polyendocrine syndrome type II

2 citations , January 2014 in “Indian Journal of Critical Care Medicine”

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

research CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE

June 2018 in “Journal of evolution of medical and dental sciences”

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

research Polyglandular autoimmune syndrome type III with a prevalence of cutaneous features

10 citations , November 2016 in “Clinical and experimental dermatology”

PAS III can cause multiple autoimmune diseases with noticeable skin issues.

View more "dispase ii" in research →

Community Join

5 / 667 results

community Breezula Phase III 12-Month Data Released by Cosmo Pharma

in Research/Science 39 upvotes 3 months ago

Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hair loss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.

community I 24F have gone from a full head of hair to ~30% of hair in 2 weeks

in Female 49 upvotes 3 years ago

A 24 year old female experiencing rapid, unexplained hair loss over the course of two weeks and looking for advice. Treatments suggested include Rogaine, finasteride, minoxidil, RU58841, and seeing a dermatologist.

community The Big Fat Layer II

in Research/Science 26 upvotes 5 years ago

Hair loss treatment should target dermal white adipose tissue (DWAT) to restore hair follicles. Potential remedies include tocopherol (vitamin E), botox, rosiglitazone, niacin, kojyl cinnamate esters, and ADP355.

community RU-58841 Lung Disease Possibility | Chest pain, "heart issues", etc

in Treatment 22 upvotes 2 years ago

Some users of RU-58841 report cardiovascular symptoms like heart palpitations and chest tightness, which may be linked to its metabolites causing lung disease. The safety of RU-58841 is uncertain due to lack of long-term data and concerns about product purity, especially from gray market sources.

community Pelage to present PP405 Phase 2a clinical trial full results at an upcoming medical meeting - CMO Christina Weng says

in Research/Science 748 upvotes 5 months ago

Pelage is moving to Phase III clinical trials for PP405, a hair loss treatment, with results to be presented at a medical meeting. Users express skepticism and hope, comparing it to existing treatments like Minoxidil and finasteride, while discussing the potential for new hair growth in previously bald areas.

View more "dispase ii" in community →

Learn

2 / 801 results

learn Overview

learn Osteopontin

signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

View more "dispase ii" in learn →

Experts

3 / 22 results

Clinics

— no results

Try a deeper search in clinics →